Literature DB >> 17292974

Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.

Katharine N Bossart1, Jennifer A McEachern, Andrew C Hickey, Vidita Choudhry, Dimiter S Dimitrov, Bryan T Eaton, Lin-Fa Wang.   

Abstract

Hendra virus (HeV) and Nipah virus (NiV) are related emerging paramyxoviruses classified in the genus Henipavirus. Both cause fatal disease in animals and humans and are classified as biosafety level 4 pathogens. Here we detail two new multiplexed microsphere assays, one for antibody detection and differentiation and another designed as a surrogate for virus neutralization. Both assays utilize recombinant soluble attachment glycoproteins (sG) whereas the latter incorporates the cellular receptor, recombinant ephrin-B2. Spectrally distinct sG(HeV)- and sG(NiV)-coupled microspheres preferentially bound antibodies from HeV- and NiV-seropositive animals, demonstrating a simple procedure to differentiate antibodies to these closely related viruses. Soluble ephrin-B2 bound sG-coupled microspheres in a dose-dependent fashion. Specificity of binding was further evaluated with henipavirus G-specific sera and MAbs. Sera from henipavirus-seropositive animals differentially blocked ephrin-B2 binding, suggesting that detection and differentiation of HeV and NiV neutralizing antibodies can be done simultaneously in the absence of live virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292974     DOI: 10.1016/j.jviromet.2007.01.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  70 in total

1.  Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Authors:  Tatyana Yun; Arnold Park; Terence E Hill; Olivier Pernet; Shannon M Beaty; Terry L Juelich; Jennifer K Smith; Lihong Zhang; Yao E Wang; Frederic Vigant; Junling Gao; Ping Wu; Benhur Lee; Alexander N Freiberg
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.

Authors:  Katharine N Bossart; Thomas W Geisbert; Heinz Feldmann; Zhongyu Zhu; Friederike Feldmann; Joan B Geisbert; Lianying Yan; Yan-Ru Feng; Doug Brining; Dana Scott; Yanping Wang; Antony S Dimitrov; Julie Callison; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Christopher C Broder; Barry Rockx
Journal:  Sci Transl Med       Date:  2011-10-19       Impact factor: 17.956

3.  Removal of species constraints in antibody detection.

Authors:  Alison Jane Basile; Brad J Biggerstaff; Olga L Kosoy; Shilpa R Junna; Nicholas A Panella; Ann M Powers; Lillian M Stark; Nicole M Nemeth
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

4.  A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.

Authors:  Katharine N Bossart; Barry Rockx; Friederike Feldmann; Doug Brining; Dana Scott; Rachel LaCasse; Joan B Geisbert; Yan-Ru Feng; Yee-Peng Chan; Andrew C Hickey; Christopher C Broder; Heinz Feldmann; Thomas W Geisbert
Journal:  Sci Transl Med       Date:  2012-08-08       Impact factor: 17.956

Review 5.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 6.  Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Authors:  Ponraj Prabakaran; Zhongyu Zhu; Xiaodong Xiao; Arya Biragyn; Antony S Dimitrov; Christopher C Broder; Dimiter S Dimitrov
Journal:  Expert Opin Biol Ther       Date:  2009-03       Impact factor: 4.388

7.  Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.

Authors:  Cheng-Feng Chiang; Michael K Lo; Paul A Rota; Christina F Spiropoulou; Pierre E Rollin
Journal:  Virol J       Date:  2010-06-03       Impact factor: 4.099

8.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

9.  Nipah virus infection: current scenario.

Authors:  D D Kulkarni; C Tosh; G Venkatesh; D Senthil Kumar
Journal:  Indian J Virol       Date:  2013-11-07

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.